Skip to main content
Equibles

Scott Morrison

Board Member

Tarsus Pharmaceuticals, Inc. (TARS)
Tarsus Pharmaceuticals, Inc. (TARS)

Equibles does not estimate personal net worth.

About Scott Morrison

Scott Morrison is recorded as Board Member at Tarsus Pharmaceuticals, Inc. (TARS). The newest filing on record that lists Scott Morrison as Board Member at Tarsus Pharmaceuticals, Inc. (TARS) is dated April 28, 2026. Tarsus Pharmaceuticals, Inc. reported in an 8-K filed October 12, 2022 that Scott Morrison was appointed Chairperson of the Audit Committee, effective October 6, 2022. Tarsus Pharmaceuticals, Inc. reported in an 8-K filed October 12, 2022 that Scott Morrison was appointed Class III director, effective October 6, 2022. Tarsus Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Tarsus Pharmaceuticals, Inc. includes Bobak Azamian (CEO and Chairman), Jeffrey S. Farrow (CFO), Leonard Greenstein (CFO) and 7 others.

“effective immediately, the Board appointed Mr. Morrison to serve as Chairperson of the Audit Committee of the Board and as member of the newly formed Commercial Committee of the Board (the “Commercial Committee”) (as described below).”
Tarsus Pharmaceuticals, Inc. Form 8-K, filed October 12, 2022 · Read the filing
“On October 6, 2022, (the “Effective Date”) the Board of Directors (the “Board”) of Tarsus Pharmaceuticals, Inc. (the “Company”), upon the recommendation of its Nominating and Corporate Governance Committee (the “Nominating Committee”), expanded the size of the Board from eight to nine directors and appointed Scott Morrison to the Board, effective immediately.”
Tarsus Pharmaceuticals, Inc. Form 8-K, filed October 12, 2022 · Read the filing

Affiliation history

Company network

Leadership on record at Tarsus Pharmaceuticals, Inc.

Recent activity